**U.S. PRODUCERS' QUESTIONNAIRE**

**FRONTSEATING SERVICE VALVES (FSVs) FROM CHINA**

**This questionnaire must be received by the Commission by no later than
April 1, 2008**

***See page 4 of the Instruction Booklet for filing instructions.***

The information called for in this questionnaire is for use by the
United States International Trade Commission in connection with its
antidumping investigation concerning FSVs from China (Inv. No.
731-TA-1148 (Preliminary)). The information requested in the
questionnaire is requested under the authority of the Tariff Act of
1930, title VII. This report is mandatory and failure to reply as
directed can result in a subpoena or other order to compel the
submission of records or information in your possession (19 U.S.C. §
1333(a)).

+-----------------------------------------------------------------------+
| > **Name of firm** [     ]{.underline}                                |
| >                                                                     |
| > **Address** [     ]{.underline}                                     |
| >                                                                     |
| > **City** [     ]{.underline} **State** [  ]{.underline} **Zip       |
| > Code** [     ]{.underline}                                          |
| >                                                                     |
| > **World Wide Web address** [     ]{.underline}                      |
| >                                                                     |
| > Has your firm produced FSVs (as defined in the instruction booklet) |
| > at any time since January 1, 2005?                                  |
| >                                                                     |
| > **NO** (Sign the certification below and promptly return only this  |
| > page of the questionnaire to the Commission)                        |
| >                                                                     |
| > **YES** (Read the instruction booklet carefully, complete all parts |
| > of the questionnaire, and return the entire                         |
| >                                                                     |
| > questionnaire to the Commission so as to be received by the date    |
| > indicated above)                                                    |
+-----------------------------------------------------------------------+

**CERTIFICATION**

***I certify that the information herein supplied in response to this
questionnaire is complete and correct to the best of my knowledge and
belief and understand that the information submitted is subject to audit
and verification by the Commission.***

***By means of this certification I also grant consent for the
Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this
investigation in any other import-injury investigations conducted by the
Commission on the same or similar merchandise.***

***I acknowledge that information submitted in this questionnaire
response and throughout this investigation may be used by the
Commission, its employees, and contract personnel who are acting in the
capacity of Commission employees, for developing or maintaining the
records of this investigation or related proceedings for which this
information is submitted, or in internal audits and investigations
relating to the programs and operations of the Commission pursuant to 5
U.S.C. Appendix 3. I understand that all contract personnel will sign
non-disclosure agreements.***

[     ]{.underline} [     ]{.underline} [     ]{.underline}

***Name of Authorized Official*** ***Title of Authorized Official
Date***

[     ]{.underline} ***Phone:*** [(   )     ]{.underline}
[     ]{.underline}

***Signature*** ***Fax*** [(   )     ]{.underline} ***E-mail address***

The questions in this questionnaire have been reviewed with market
participants to ensure that issues of concern are adequately addressed
and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to
average 50 hours per response, including the time for reviewing
instructions, searching existing data sources, gathering the data
needed, and completing and reviewing the questionnaire. Send comments
regarding the accuracy of this burden estimate or any other aspect of
this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade
Commission, 500 E Street, SW, Washington, DC 20436.

I-1a. Please report below the actual number of hours required and the
cost to your firm of preparing the reply to this questionnaire and
completing the form.

[     ]{.underline} hours [     ]{.underline} dollars

I-1b. We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please
attach such comments to your response or send them to the above address.

I-2. Provide the name and address of establishment(s) covered by this
questionnaire (see page 3 of the instruction booklet for reporting
guidelines). If your firm is publicly traded, please specify the stock
exchange and trading symbol.

> [     \
> \
> ]{.underline}

I-3. Do you support or oppose the petition?

  ------------------------------------------ ----------------------------
  Support Oppose Take no position            

  ------------------------------------------ ----------------------------

> [     ]{.underline}

I-4. Is your firm owned, in whole or in part, by any other firm?

> No Yes\--List the following information

  ----------------------- -------------------------------- ------------------------
  [Firm name]{.underline} [Address]{.underline}            [Extent of
                                                           ownership]{.underline}

  [     ]{.underline}     [     ]{.underline}              [     ]{.underline}

  [     ]{.underline}     [     ]{.underline}              [     ]{.underline}

  [     ]{.underline}     [     ]{.underline}              [     ]{.underline}
  ----------------------- -------------------------------- ------------------------

I-5. Does your firm have any related firms, either domestic or foreign,
which are engaged in importing FSVs from China into the United States or
which are engaged in exporting FSVs from China to the United States?

> No Yes\--List the following information

  ----------------------- -------------------------- ---------------------------
  [Firm name]{.underline} [Address]{.underline}      [Affiliation]{.underline}

  [     ]{.underline}     [     ]{.underline}        [     ]{.underline}

  [     ]{.underline}     [     ]{.underline}        [     ]{.underline}

  [     ]{.underline}     [     ]{.underline}        [     ]{.underline}
  ----------------------- -------------------------- ---------------------------

I-6. Does your firm have any related firms, either domestic or foreign,
which are engaged in the production of FSVs?

> No Yes\--List the following information

  ----------------------- -------------------------- ---------------------------
  [Firm name]{.underline} [Address]{.underline}      [Affiliation]{.underline}

  [     ]{.underline}     [     ]{.underline}        [     ]{.underline}

  [     ]{.underline}     [     ]{.underline}        [     ]{.underline}

  [     ]{.underline}     [     ]{.underline}        [     ]{.underline}
  ----------------------- -------------------------- ---------------------------

Further information on this part of the questionnaire can be obtained
from Dana Lofgren, Investigator (202-205-3185, dana.lofgren@usitc.gov).
**Supply** **all data requested on a [calendar-year]{.underline}
basis**.

II-1. Who should be contacted regarding the requested trade and related
information?

> Company contact: [     ]{.underline}
>
> Name and title
>
> [(   )      ]{.underline} [     ]{.underline}
>
> Phone number E-mail address

II-2. Has your firm experienced any plant openings, relocations,
expansions, acquisitions, consolidations, closures, or prolonged
shutdowns because of strikes or equipment failure; curtailment of
production because of shortages of materials; or any other change in the
character of your operations or organization relating to the production
of FSVs since January 1, 2005?

> No Yes\--Supply details as to the time, nature, and significance of
> such changes.
>
> [     \
> \
> ]{.underline}

II-3. Does your firm produce other products on the same equipment and
machinery used in the production of FSVs?

> No Yes\--List the following information.
>
> Basis for allocation of capacity data (*e.g.*, sales):
> [     ]{.underline}
>
> Products produced on same equipment and share of total production in
> 2007 (in percent):

  ----------------------------------------------- -----------------------
  [Product]{.underline}                           [Percent]{.underline}

  [FSVs]{.underline}                              [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}
  ----------------------------------------------- -----------------------

II-4. Please describe the constraint(s) that set the limit(s) on your
production capacity and your ability to shift production capacity
between products.

> [     \
> \
> ]{.underline}

II-5. Does your firm produce other products using the same production
and related workers employed to produce FSVs?

> No Yes\--List the following information.
>
> Basis for allocation of capacity data (*e.g.*, sales):
> [     ]{.underline}
>
> Products produced using the same workers and share of total production
> in 2007 (in percent):

  ------------------------------------------------ -----------------------
  [Product]{.underline}                            [Percent]{.underline}

  [FSVs]{.underline}                               [     ]{.underline}

  [     ]{.underline}                              [     ]{.underline}

  [     ]{.underline}                              [     ]{.underline}

  [     ]{.underline}                              [     ]{.underline}

  [     ]{.underline}                              [     ]{.underline}

                                                   
  ------------------------------------------------ -----------------------

II-6. Since January 1, 2005, has your firm been involved in a toll
agreement (see definition in the instruction booklet) regarding the
production of FSVs?

> No Yes\--Name firm(s): [     ]{.underline} .

II-7. Does your firm produce FSVs in a foreign trade zone (FTZ)?

> No Yes\--Identify FTZ(s): [     ]{.underline} .

II-8. Since January 1, 2005, has your firm imported FSVs?

> No Yes\--***[COMPLETE AND RETURN A U.S. IMPORTERS'
> QUESTIONNAIRE]{.underline}***

II-9. Report your firm's production capacity, production, shipments,
inventories, and employment related to the production of FSVs in your
U.S. establishment(s) during the specified periods. (See definitions in
the instruction booklet.)

+---------------------------+-------+----+---+-------+---+----+-------+
| **Quantity (*in 1,000     |       |    |   |       |   |    |       |
| units*) and value (*in    |       |    |   |       |   |    |       |
| \$1,000*)**               |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Item**                  | **Cal |    |   |       |   |    |       |
|                           | endar |    |   |       |   |    |       |
|                           | ye    |    |   |       |   |    |       |
|                           | ars** |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
|                           | **2   |    | * |       |   | ** |       |
|                           | 005** |    | * |       |   | 20 |       |
|                           |       |    | 2 |       |   | 07 |       |
|                           |       |    | 0 |       |   | ** |       |
|                           |       |    | 0 |       |   |    |       |
|                           |       |    | 6 |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Average production      |       |    |   |       |   |    |       |
| capacity^1^**             |       |    |   |       |   |    |       |
| (*quantity*)              |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Beginning-of-period     |       |    |   |       |   |    |       |
| inventories**             |       |    |   |       |   |    |       |
| (*quantity*)              |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Production**            |       |    |   |       |   |    |       |
| (*quantity*)              |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **U.S. shipments:**       |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Commercial shipments:** |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity* of commercial  |       |    |   |       |   |    |       |
| shipments                 |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value* of commercial     | **    |    | * |       |   | *  |       |
| shipments                 |    ** |    | * |       |   | *  |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   | ** |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Internal consumption:** |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity* of internal    |       |    |   |       |   |    |       |
| consumption               |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value^2^* of internal    | **    |    | * |       |   | *  |       |
| consumption               |    ** |    | * |       |   | *  |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   | ** |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Transfers to related    |       |    |   |       |   |    |       |
| firms:**                  |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity* of transfers   |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value^2^* of transfers   | **    |    | * |       |   | *  |       |
|                           |    ** |    | * |       |   | *  |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   | ** |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Export shipments:^3^**  |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity* of export      |       |    |   |       |   |    |       |
| shipments                 |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value* of export         | **    |    | * |       |   | *  |       |
| shipments                 |    ** |    | * |       |   | *  |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   | ** |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **End-of-period           | **    |    | * |       |   | *  |       |
| inventories^4^**          |    ** |    | * |       |   | *  |       |
| (*quantity*)              |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   | ** |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Channels of             |       |    |   |       |   |    |       |
| distribution:**           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| U.S. shipments to         |       |    |   |       |   |    |       |
| distributors (*quantity*) |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| U.S. shipments to end     |       |    |   |       |   |    |       |
| users (*quantity*)        |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Employment data:**      |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Average number of PRWs    | **    |    | * |       |   | *  |       |
| (*number*)                |    ** |    | * |       |   | *  |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   | ** |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Hours worked by PRWs      |       |    |   |       |   |    |       |
| (*1,000 hours*)           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Wages paid to PRWs        | **    |    | * |       |   | *  |       |
| (*value*)                 |    ** |    | * |       |   | *  |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   | ** |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| ^1^ The production        |       |    |   |       |   |    |       |
| capacity (see definitions |       |    |   |       |   |    |       |
| in instruction booklet)   |       |    |   |       |   |    |       |
| reported is based on      |       |    |   |       |   |    |       |
| operating                 |       |    |   |       |   |    |       |
| [     ]{.underline} hours |       |    |   |       |   |    |       |
| per week,                 |       |    |   |       |   |    |       |
| [     ]{.underline} weeks |       |    |   |       |   |    |       |
| per year. Please describe |       |    |   |       |   |    |       |
| the methodology used to   |       |    |   |       |   |    |       |
| calculate production      |       |    |   |       |   |    |       |
| capacity, and explain any |       |    |   |       |   |    |       |
| changes in reported       |       |    |   |       |   |    |       |
| capacity (use additional  |       |    |   |       |   |    |       |
| pages as necessary).      |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| [     \                   |       |    |   |       |   |    |       |
| ]{.underline}             |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| ^2^ Internal consumption  |       |    |   |       |   |    |       |
| and transfers to related  |       |    |   |       |   |    |       |
| firms must be valued at   |       |    |   |       |   |    |       |
| fair market value. In the |       |    |   |       |   |    |       |
| event that you use a      |       |    |   |       |   |    |       |
| different basis for       |       |    |   |       |   |    |       |
| valuing these             |       |    |   |       |   |    |       |
| transactions, please      |       |    |   |       |   |    |       |
| specify that basis        |       |    |   |       |   |    |       |
| (*e.g.*, cost, cost plus, |       |    |   |       |   |    |       |
| *etc.*) and provide value |       |    |   |       |   |    |       |
| data using that basis for |       |    |   |       |   |    |       |
| 2005, 2006, and 2007      |       |    |   |       |   |    |       |
| below:                    |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| [     \                   |       |    |   |       |   |    |       |
| ]{.underline}             |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| ^3^ Identify your         |       |    |   |       |   |    |       |
| principal export markets: |       |    |   |       |   |    |       |
| [     ]{.underline} .     |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| ^4^ Reconciliation of     |       |    |   |       |   |    |       |
| data.\--Please note that  |       |    |   |       |   |    |       |
| the **quantities**        |       |    |   |       |   |    |       |
| reported above should     |       |    |   |       |   |    |       |
| reconcile as follows:     |       |    |   |       |   |    |       |
| beginning-of-period       |       |    |   |       |   |    |       |
| inventories, plus         |       |    |   |       |   |    |       |
| production, less total    |       |    |   |       |   |    |       |
| shipments, equals         |       |    |   |       |   |    |       |
| end-of-period             |       |    |   |       |   |    |       |
| inventories. Do the data  |       |    |   |       |   |    |       |
| reported reconcile?       |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| Yes No\--Please explain:  |       |    |   |       |   |    |       |
| [     ]{.underline} .     |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+

II-10. If you reported transfers to related firms in question II-9,
please indicate the nature of the relationship between your firm and the
related firms (*e.g.*, joint venture, wholly owned subsidiary), whether
the transfers were priced at market value or by a non-market formula,
whether your firm retained marketing rights to all transfers, and
whether the related firms also processed inputs from sources other than
your firm.

> [     \
> ]{.underline}

II-11. Other than direct imports, has your firm otherwise purchased FSVs
since January 1, 2005? (See definitions in the instruction booklet.)

> No Yes\--Report such purchases below for the specified periods.^1^

+---------------------------+-------+----+---+-------+---+----+-------+
| **(Quantity *in 1,000     |       |    |   |       |   |    |       |
| units*, value *in         |       |    |   |       |   |    |       |
| \$1,000*)**               |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Item**                  | **Cal |    |   |       |   |    |       |
|                           | endar |    |   |       |   |    |       |
|                           | ye    |    |   |       |   |    |       |
|                           | ars** |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
|                           | **2   |    | * |       |   | ** |       |
|                           | 005** |    | * |       |   | 20 |       |
|                           |       |    | 2 |       |   | 07 |       |
|                           |       |    | 0 |       |   | ** |       |
|                           |       |    | 0 |       |   |    |       |
|                           |       |    | 6 |       |   |    |       |
|                           |       |    | * |       |   |    |       |
|                           |       |    | * |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **PURCHASES FROM U.S.     |       |    |   |       |   |    |       |
| IMPORTERS**^2^ **OF FSVs  |       |    |   |       |   |    |       |
| FROM\--**                 |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| China:                    |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity*                |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value*                   |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| All other countries:      |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity*                |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value*                   |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **PURCHASES FROM DOMESTIC |       |    |   |       |   |    |       |
| PRODUCERS:^2^**           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity*                |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value*                   |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **PURCHASES FROM OTHER    |       |    |   |       |   |    |       |
| SOURCES:**^2^             |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Quantity*                |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| *Value*                   |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| ^1^ Please indicate your  |       |    |   |       |   |    |       |
| reasons for purchasing    |       |    |   |       |   |    |       |
| this product. If your     |       |    |   |       |   |    |       |
| reasons differ by source, |       |    |   |       |   |    |       |
| please elaborate.         |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| [     \                   |       |    |   |       |   |    |       |
| ]{.underline}             |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| ^2^ Please list the name  |       |    |   |       |   |    |       |
| of the firm(s) from which |       |    |   |       |   |    |       |
| you purchased this        |       |    |   |       |   |    |       |
| product. If your          |       |    |   |       |   |    |       |
| suppliers differ by       |       |    |   |       |   |    |       |
| source, please identify   |       |    |   |       |   |    |       |
| the source for each       |       |    |   |       |   |    |       |
| listed supplier.          |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| [     \                   |       |    |   |       |   |    |       |
| ]{.underline}             |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+

Address questions on this part of the questionnaire to Charles Yost,
Auditor (202-205-3432, charles.yost@usitc.gov).

III-1. Who should be contacted regarding the requested financial
information?

> Company contact: [     ]{.underline}
>
> Name and title
>
> [(   )      ]{.underline} [     ]{.underline}
>
> Phone number E-mail address

III-2. Briefly describe your financial accounting system.

> A. When does your fiscal year end (month and day)? [     ]{.underline}
>
> If your fiscal year changed during the period examined, explain below:
>
> [     ]{.underline}
>
> B.1. Describe the lowest level of operations (e.g., plant, division,
> company-wide) for which financial statements are prepared that include
> subject merchandise:
>
> [     ]{.underline}
>
> 2\. Does your firm prepare profit/loss statements for the subject
> merchandise:
>
> Yes No
>
> 3\. How often did your firm (or parent company) prepare financial
> statements (including annual reports, 10Ks)? Please check relevant
> items below.
>
> Audited, unaudited, annual reports, 10Ks, 10 Qs,
>
> Monthly, quarterly, semi-annually, annually
>
> 4\. Accounting basis: GAAP, cash, tax, or other comprehensive
> (specify) [     ]{.underline}
>
> *Note: The Commission may request that your company submit copies of
> its financial statements, including internal profit-and-loss
> statements for the division or product group that includes FSVs, as
> well as those statements and worksheets used to compile data for your
> firm's questionnaire response.*

III-3. Briefly describe your cost accounting system (*e.g.*, standard
cost, job order cost, *etc.*).

> [     \
> \
> ]{.underline}

III-4. Briefly describe your allocation basis, if any, for COGS, SG&A,
and interest expense and other income and expenses.

> [     \
> \
> ]{.underline}

III-5. [Other products]{.underline}.\--Please list any other products
you produced in the facilities in which you produced FSVs, and provide
the share of net sales accounted for by these other products in your
most recent fiscal year:

  ------------------------------------------------------ ---------------------
  [Products]{.underline}                                 [Share of
                                                         sales]{.underline}

  [     ]{.underline}                                    [     ]{.underline}

  [     ]{.underline}                                    [     ]{.underline}

  [     ]{.underline}                                    [     ]{.underline}

  [     ]{.underline}                                    [     ]{.underline}

  [     ]{.underline}                                    [     ]{.underline}
  ------------------------------------------------------ ---------------------

III-6. Does your firm receive inputs (raw materials, labor, energy, or
any other services) used in the production of FSVs from any related
firm?

> Yes---Continue to question III-7 below. No\--Continue to question
> III-10 below.

III-7. In the space provided below, identify the inputs related to the
production of FSVs that your firm receives from related parties whose
financial statements are consolidated with the financial statements of
your firm.

  ---------------------------------- ------------------------------------
  [Input]{.underline}                [Related party]{.underline}

  [     ]{.underline}                [     ]{.underline}

  [     ]{.underline}                [     ]{.underline}

  [     ]{.underline}                [     ]{.underline}

  [     ]{.underline}                [     ]{.underline}

  [     ]{.underline}                [     ]{.underline}
  ---------------------------------- ------------------------------------

III-8. With respect to the related companies identified in response to
question III-7 above, are their financial statements consolidated with
your firm's financial statements? (In other words, are profits or losses
arising from intercompany transactions eliminated?

> Yes---Continue to question III-9 below. No\--Continue to question
> III-10 below.

III-9. All intercompany profit on inputs [purchased from related
parties]{.underline} that is eliminated pursuant to formal financial
statement consolidation should also be eliminated from the costs
reported to the Commission in question III-11 (i.e., costs reported in
question III-11, to the extent that they reflect inputs purchased from
related parties, should only reflect the related party's cost and not
include an associated profit component). Reasonable methods for
determining and eliminating the associated profit on inputs purchased
from related parties are acceptable.

Has your firm complied with the Commission's instructions regarding
costs associated with inputs purchased from related parties?

> Yes No---Please contact Charles Yost, Auditor (202-205-3432,
> charles.yost@usitc.gov).

III-10. [Nonrecurring charges]{.underline}.\--For each annual period for
which financial results are reported in question III-11, please indicate
in the schedule below the specific nonrecurring charges, the particular
expense/cost line items from question III-11 where the associated
charges are included, a brief description of the charges, and the
associated values (*in \$1,000*). Nonrecurring charges would include,
but are not limited to, items such as asset write-offs and accelerated
depreciation due to restructuring of the company's FSVs operations.

  ------------------------------- --------------------- ----- --------------------- ------- -- --------------------- -------
  **Item**                        **Fiscal years                                                                     
                                  ended\--**                                                                         

                                  [     ]{.underline}         [     ]{.underline}              [     ]{.underline}   

  **Non-recurring charges:** (In                                                                                     
  this column please provide a                                                                                       
  brief description of each                                                                                          
  nonrecurring charge and                                                                                            
  indicate the particular                                                                                            
  expense/cost line items where                                                                                      
  the associated charges are                                                                                         
  included in question III-11.)                                                                                      

  1\.                                                                                                                

  2\.                                                                                                                

  3\.                                                                                                                

  4\.                                                                                                                

  5\.                                                                                                                

  6\.                                                                                                                

  7\.                                                                                                                
  ------------------------------- --------------------- ----- --------------------- ------- -- --------------------- -------

III-11. [Operations on FSVs]{.underline}.\--Report the revenue and
related cost information requested below on the FSVs operations of your
U.S. establishment(s).^1^ Do not report resales of FSVs that your firm
merely purchased. Note that internal consumption and transfers to
related firms must be valued at fair market value and purchases from
related firms must be at cost.^2^ Provide data for your three most
recently completed fiscal years in chronological order from left to
right. If your firm was involved in tolling operations (either as the
toller or as the tollee) please contact Charles Yost, Auditor at (202)
205-3432 before completing this section of the questionnaire.

+---------------------------+-------+----+---+-------+---+----+-------+
| **Quantity (*in 1,000     |       |    |   |       |   |    |       |
| units*) and value (*in    |       |    |   |       |   |    |       |
| \$1,000*)**               |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Item**                  | **F   |    |   |       |   |    |       |
|                           | iscal |    |   |       |   |    |       |
|                           | years |    |   |       |   |    |       |
|                           | ended |    |   |       |   |    |       |
|                           | \--** |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
|                           | [     |    | [ |       |   | [  |       |
|                           |   ]{. |    |   |       |   |    |       |
|                           | under |    |   |       |   |    |       |
|                           | line} |    |   |       |   |  ] |       |
|                           |       |    |   |       |   | {. |       |
|                           |       |    |   |       |   | un |       |
|                           |       |    | ] |       |   | de |       |
|                           |       |    | { |       |   | rl |       |
|                           |       |    | . |       |   | in |       |
|                           |       |    | u |       |   | e} |       |
|                           |       |    | n |       |   |    |       |
|                           |       |    | d |       |   |    |       |
|                           |       |    | e |       |   |    |       |
|                           |       |    | r |       |   |    |       |
|                           |       |    | l |       |   |    |       |
|                           |       |    | i |       |   |    |       |
|                           |       |    | n |       |   |    |       |
|                           |       |    | e |       |   |    |       |
|                           |       |    | } |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Net sales               |       |    |   |       |   |    |       |
| quantities:**^3^          |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Commercial sales          |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Internal consumption      |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Transfers to related      |       |    |   |       |   |    |       |
| firms                     |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Total net sales           |       |    |   |       |   |    |       |
| quantities                |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Net sales values:**^3^  |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Commercial sales          |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Internal consumption      |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Transfers to related      |       |    |   |       |   |    |       |
| firms                     |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Total net sales values    |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Cost of goods sold      |       |    |   |       |   |    |       |
| (COGS):**^4^              |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Raw materials             |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Direct labor              |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Other factory costs       |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Total COGS                |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Gross profit or         |       |    |   |       |   |    |       |
| (loss)**                  |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Selling, general, and   |       |    |   |       |   |    |       |
| administrative (SG&A)     |       |    |   |       |   |    |       |
| expenses:**               |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Selling expenses          |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| General and               |       |    |   |       |   |    |       |
| administrative expenses   |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Total SG&A expenses       |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Operating income        |       |    |   |       |   |    |       |
| (loss)**                  |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Other income and        |       |    |   |       |   |    |       |
| expenses:**               |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| Interest expense          |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| All other expense items   |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| All other income items    |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| All other income or       |       |    |   |       |   |    |       |
| expenses, net             |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **Net income or (loss)    |       |    |   |       |   |    |       |
| before income taxes**     |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| **                        |       |    |   |       |   |    |       |
| Depreciation/amortization |       |    |   |       |   |    |       |
| included above**          |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+
| ^1^ Include only sales    |       |    |   |       |   |    |       |
| (whether domestic or      |       |    |   |       |   |    |       |
| export) and costs related |       |    |   |       |   |    |       |
| to your U.S.              |       |    |   |       |   |    |       |
| manufacturing operations. |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| ^2^ Please list the       |       |    |   |       |   |    |       |
| expense categories and    |       |    |   |       |   |    |       |
| amounts of any profits on |       |    |   |       |   |    |       |
| internal inputs or inputs |       |    |   |       |   |    |       |
| from related firms that   |       |    |   |       |   |    |       |
| are reflected on your     |       |    |   |       |   |    |       |
| books but which are       |       |    |   |       |   |    |       |
| eliminated from the costs |       |    |   |       |   |    |       |
| reported below.           |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| ^3^ Less discounts,       |       |    |   |       |   |    |       |
| returns, allowances, and  |       |    |   |       |   |    |       |
| prepaid freight. The      |       |    |   |       |   |    |       |
| quantities and values     |       |    |   |       |   |    |       |
| should approximate the    |       |    |   |       |   |    |       |
| corresponding shipment    |       |    |   |       |   |    |       |
| quantities and values     |       |    |   |       |   |    |       |
| reported in Part II of    |       |    |   |       |   |    |       |
| this questionnaire.       |       |    |   |       |   |    |       |
|                           |       |    |   |       |   |    |       |
| ^4^ COGS should include   |       |    |   |       |   |    |       |
| costs associated with     |       |    |   |       |   |    |       |
| internal consumption and  |       |    |   |       |   |    |       |
| transfers to related      |       |    |   |       |   |    |       |
| firms.                    |       |    |   |       |   |    |       |
+---------------------------+-------+----+---+-------+---+----+-------+

III-12. [Asset values]{.underline}.\--Report the total assets associated
with the production, warehousing, and sale of FSVs. If your firm does
not maintain some or all of the specific asset data in the normal course
of business, please estimate it based upon some rational method (such as
production, sales, or costs) that is consistent with your cost
allocations in the previous question. Your finished goods inventory
value should reconcile with the inventory quantity data reported in Part
II. Provide data as of the end of your three most recently completed
fiscal years in chronological order from left to right.

  --------------------------- --------------------- --------------------- ---------------------
  **Value (*in \$1,000*)**                                                

  **Item**                    **Fiscal years                              
                              ended\--**                                  

                              [     ]{.underline}   [     ]{.underline}   [     ]{.underline}

  **Assets associated with                                                     
  the production,                                                         
  warehousing, and sale of                                                
  product:**                                                              

  **1.** Current assets:                                                       

  A. Cash and equivalents                                                      

  B. Accounts receivable, net                                                  

  C. Inventories (finished                                                     
  goods)                                                                  

  D. Inventories (raw                                                          
  materials and work in                                                   
  process)                                                                

  E. Other (describe:                                                          
  [     ]{.underline} )                                                   

  F. Total current assets                                                      
  (lines 1.A. through 1.E.)                                               

  **2.** Property, plant, and                                                  
  equipment                                                               

  A. Original cost of                                                          
  property, plant, and                                                    
  equipment                                                               

  B. Less: Accumulated                                                         
  depreciation                                                            

  C. Equals: Book value of                                                     
  property, plant, and                                                    
  equipment                                                               

  **3.** Other (describe:                                                      
  [     ]{.underline})                                                    

  **4.** Other (describe:                                                      
  [     ]{.underline})                                                    

  **5. Total assets** (lines                                                   
  1.F., 2.C., 3 and 4)                                                    
  --------------------------- --------------------- --------------------- ---------------------

III-13. [Capital expenditures and research and development
expenditures]{.underline}.\--Report your firm's capital expenditures and
research and development expenditures on FSVs. Provide data for your
three most recently completed fiscal years in chronological order from
left to right.

  --------------------------- --------------------- --------------------- ---------------------
  **Value (*in \$1,000*)**                                                

  **Item**                    **Fiscal years                              
                              ended\--**                                  

                              [     ]{.underline}   [     ]{.underline}   [     ]{.underline}

  **Capital expenditures**                                                     

  **Research and development                                                   
  expenditures**                                                          
  --------------------------- --------------------- --------------------- ---------------------

III-14. Since January 1, 2005, has your firm experienced any actual
negative effects on its return on investment or its growth, investment,
ability to raise capital, existing development and production efforts
(including efforts to develop a derivative or more advanced version of
the product), or the scale of capital investments as a result of imports
of FSVs from China?

> No Yes\--My firm has experienced actual negative effects as follows:
>
> Cancellation, postponement, or rejection of expansion projects
>
> Denial or rejection of investment proposal
>
> Reduction in the size of capital investments
>
> Rejection of bank loans
>
> Lowering of credit rating
>
> Problem related to the issue of stocks or bonds
>
> Other (specify) [     ]{.underline}

III-15. Does your firm anticipate any negative impact of imports of FSVs
from China?

> [     \
> \
> ]{.underline}

Further information on this part of the questionnaire can be obtained
from Nancy Bryan, Economist (202-205-2088, e-mail
<nancy.bryan@usitc.gov>).

IV-1. Who should be contacted regarding the requested pricing and
related information?

> Company contact: [     ]{.underline}
>
> Name and title
>
> [(   )      ]{.underline} [     ]{.underline}
>
> Phone number E-mail address

**[PRICE DATA]{.underline}**

This section requests quarterly selling quantity and value data during
January 2005-December 2007 concerning your firm's U.S. commercial
shipments of its U.S.-produced FSVs to its U.S. OEM customers *unrelated
by ownership to your firm* for the following FSV products:

***[Product 1]{.underline}*. \-- 3/8 inch---SAE---6 size: Frontseating
service valves that have brass bodies with copper tube extensions,
double 90-degree flow pattern, metal-to-metal seating, with Schraeder
Bridgeport access valves and captivated stem with OD solder connection
of 3/8 inch.**

***[Product 2]{.underline}*.\-- 3/4 inch---SAE---12 size: Frontseating
service valves that have brass bodies with copper tube extensions,
double 90-degree flow pattern, metal-to-metal seating, with Schraeder
Bridgeport access valves and captivated stem with OD solder connection
of 3/4 inch.**

***[Product 3]{.underline}*.\-- 7/8 inch---SAE---14 size: Frontseating
service valves that have brass bodies with copper tube extensions,
double 90-degree flow pattern, metal-to-metal seating, with Schraeder
Bridgeport access valves and captivated stem with OD solder connection
of 7/8 inch.**

**Please note that total dollar values should be your firm's f.o.b.,
U.S. point(s) of shipment values and should not include U.S.-inland
transportation costs to your firm's U.S. OEM customers. Total dollar
values should reflect the *final net* amount paid to you (i.e., should
be net of all deductions for discounts or rebates). See instruction
booklet.**

**Report the requested pricing data in the table on the following
page.**

IV-2a. Report below the quarterly price data^1^ for the specified
pricing products^2^ that your firm produced domestically and sold to its
U.S. OEM customers.

+--------------+-------+--------+-------+--------+--------+----------+
| **(Quantity  |       |        |       |        |        |          |
| *in units*,  |       |        |       |        |        |          |
| value *in    |       |        |       |        |        |          |
| dollars*)**  |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| **Period of  | **Pr  |        | **Pr  |        | **P    |          |
| shipment**   | oduct |        | oduct |        | roduct |          |
|              | 1**   |        | 2**   |        | 3**    |          |
+--------------+-------+--------+-------+--------+--------+----------+
|              | **    | **V    | **    | **V    | **Quan | *        |
|              | Quant | alue** | Quant | alue** | tity** | *Value** |
|              | ity** |        | ity** |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| **2005**     |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| J            |       |        |       |        |        |          |
| anuary-March |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| April-June   |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| Ju           |       |        |       |        |        |          |
| ly-September |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| Octo         |       |        |       |        |        |          |
| ber-December |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| **2006**     |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| J            |       |        |       |        |        |          |
| anuary-March |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| April-June   |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| Ju           |       |        |       |        |        |          |
| ly-September |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| Octo         |       |        |       |        |        |          |
| ber-December |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| **2007**     |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| J            |       |        |       |        |        |          |
| anuary-March |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| April-June   |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| Ju           |       |        |       |        |        |          |
| ly-September |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| Octo         |       |        |       |        |        |          |
| ber-December |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+
| ^1^ Net      |       |        |       |        |        |          |
| values       |       |        |       |        |        |          |
| (i.e., gross |       |        |       |        |        |          |
| sales values |       |        |       |        |        |          |
| less all     |       |        |       |        |        |          |
| discounts,   |       |        |       |        |        |          |
| allowances,  |       |        |       |        |        |          |
| rebates,     |       |        |       |        |        |          |
| prepaid      |       |        |       |        |        |          |
| freight, and |       |        |       |        |        |          |
| the value of |       |        |       |        |        |          |
| returned     |       |        |       |        |        |          |
| goods),      |       |        |       |        |        |          |
| f.o.b. your  |       |        |       |        |        |          |
| firm's U.S.  |       |        |       |        |        |          |
| point(s) of  |       |        |       |        |        |          |
| shipment.    |       |        |       |        |        |          |
|              |       |        |       |        |        |          |
| ^2^ Pricing  |       |        |       |        |        |          |
| product      |       |        |       |        |        |          |
| definitions  |       |        |       |        |        |          |
| are provided |       |        |       |        |        |          |
| on the first |       |        |       |        |        |          |
| page of Part |       |        |       |        |        |          |
| IV.          |       |        |       |        |        |          |
|              |       |        |       |        |        |          |
| Note.\--If   |       |        |       |        |        |          |
| your product |       |        |       |        |        |          |
| does not     |       |        |       |        |        |          |
| exactly meet |       |        |       |        |        |          |
| the product  |       |        |       |        |        |          |
| sp           |       |        |       |        |        |          |
| ecifications |       |        |       |        |        |          |
| but is       |       |        |       |        |        |          |
| competitive  |       |        |       |        |        |          |
| with the     |       |        |       |        |        |          |
| specified    |       |        |       |        |        |          |
| product,     |       |        |       |        |        |          |
| provide a    |       |        |       |        |        |          |
| description  |       |        |       |        |        |          |
| of your      |       |        |       |        |        |          |
| product:     |       |        |       |        |        |          |
|              |       |        |       |        |        |          |
| [Product 1:  |       |        |       |        |        |          |
|      \       |       |        |       |        |        |          |
| Product 2:   |       |        |       |        |        |          |
|      ]       |       |        |       |        |        |          |
| {.underline} |       |        |       |        |        |          |
|              |       |        |       |        |        |          |
| [Product 3:  |       |        |       |        |        |          |
|      ]       |       |        |       |        |        |          |
| {.underline} |       |        |       |        |        |          |
+--------------+-------+--------+-------+--------+--------+----------+

IV-3. Please describe how your firm determines the prices that it
charges for sales of its U.S.-produced

FSVs (transaction by transaction negotiation, contracts for multiple
shipments, set price lists, etc.). If your firm issues price lists,
please include a copy of a recent price list with your submission. If
your price list is large, please submit sample pages.

> [     \
> \
> ]{.underline}

IV-4. Please describe your firm's discount policy for its U.S.-produced
FSVs (quantity discounts, annual total volume discounts, *etc.*).

> [     \
> \
> ]{.underline}

IV-5. What are your firm's typical sales terms for its U.S.-produced
FSVs (e.g., 2/10 net 30 days)? [     ]{.underline} . On what basis are
your prices of domestic FSVs usually quoted (e.g., f.o.b. warehouse, or
delivered)? [     ]{.underline} .

IV-6. Approximately what share of your firm's total U.S. commercial
shipment value of its U.S.-produced FSVs in 2007 were on a (1) long-term
contract basis (multiple deliveries for more than 12 months), (2)
short-term contract basis (multiple deliveries up to and including 12
months), and (3) spot sales basis (for a single delivery)?

  ------------------------------------ ----------------------------------
  [Type of sale]{.underline}           [Share of 2007 commercial shipment
                                       value (percent)]{.underline}

  Long-term contracts                  [     ]{.underline}

  Short-term contracts                 [     ]{.underline}

  Spot sales                           [     ]{.underline}
  ------------------------------------ ----------------------------------

IV-7. If your firm sells its U.S.-produced FSVs on a long-term contract
basis, please answer the following questions with respect to provisions
of a typical long-term contract.

> \(a\) What is the average duration of a contract? [     ]{.underline}
>
> \(b\) Can prices be renegotiated during the contract period?
> [     ]{.underline}
>
> \(c\) Does the contract fix quantity, price, or both?
> [     ]{.underline}
>
> \(d\) Does the contract have a meet or release provision?
> [     ]{.underline}

IV-8. If your firm sells its U.S.-produced FSVs on a short-term contract
basis, please answer the following questions with respect to provisions
of a typical short-term contract.

> \(a\) What is the average duration of a contract? [     ]{.underline}
>
> \(b\) Can prices be renegotiated during the contract period?
> [     ]{.underline}
>
> \(c\) Does the contract fix quantity, price, or both?
> [     ]{.underline}
>
> \(d\) Does the contract have a meet or release provision?
> [     ]{.underline}

IV-9. What is the average lead time between a customer's order and the
date of delivery for your firm's sales of its U.S.-produced FSVs?

+-----------------------+------------------+---------------------------+
| Source                | Share of 2007    | Lead time (days)          |
|                       | commercial       |                           |
|                       | shipment value   |                           |
|                       | (percent)        |                           |
+-----------------------+------------------+---------------------------+
| From inventory        | > [              | [     ]{.underline}       |
|                       |    ]{.underline} |                           |
+-----------------------+------------------+---------------------------+
| Produced to order     | > [              | [     ]{.underline}       |
|                       |    ]{.underline} |                           |
+-----------------------+------------------+---------------------------+
| **Total**             | **100 %**        |                           |
+-----------------------+------------------+---------------------------+

IV-10. (a) What is the approximate percentage of the total delivered
cost of your firm's U.S.-produced FSVs that is accounted for by U.S.
inland transportation costs? [     ]{.underline} percent.

> \(b\) Who generally arranges the transportation to your customers'
> locations? (check one) Your firm or purchaser
>
> \(c\) What proportion of your sales occur within 100 miles of your
> storage or production facility? [     ]{.underline} percent. Within
> 101 to 1,000 miles? [     ]{.underline} percent. Over 1,000 miles?
> [     ]{.underline} percent.

IV-11. What is the geographic market area in the United States served by
your firm's U.S.-produced FSVs? (check all that apply)

> Northeast Mid-Atlantic Midwest Southeast
>
> Southwest Rocky Mountains West Coast Northwest
>
> National Other (describe: [     ]{.underline} )

IV-12. Describe the end uses of your firm's U.S.-produced FSVs. For each
end-use product, estimate the percentage of the total cost is accounted
for by FSVs?

  ------------------------------------------ ----------------------------
  [End use]{.underline}                      [Share of total cost
                                             (percent)]{.underline}

  [     ]{.underline}                        [     ]{.underline}

  [     ]{.underline}                        [     ]{.underline}

  [     ]{.underline}                        [     ]{.underline}

  [     ]{.underline}                        [     ]{.underline}
  ------------------------------------------ ----------------------------

IV-13. (a) Please list in order of importance any products that may be
substituted for FSVs.

> \(i\) [     ]{.underline}
>
> \(ii\) [     ]{.underline}
>
> \(iii\) [     ]{.underline}

\(b\) For each possible substitute product, please give examples of
applications and end uses for which they are substitutes.

> [     \
> \
> ]{.underline}

\(c\) Have changes in the prices of these products affected the price
for FSVs?

> No Yes\-- To what degree do changes in their prices affect the price
> for FSVs? Does this effect have a time lag? If so, how long is the
> time lag for each substitute product? Does this vary by type of FSVs
> or final end use?
>
> [     \
> \
> ]{.underline}

IV-14. How has the demand within the United States (and outside the
United States if known) for FSVs changed since January 1, 2005? What
principal factors affect changes in demand?

> Increased No change Decreased
>
> [     \
> \
> ]{.underline}

IV-15. Have there been any significant changes in the product range or
marketing of FSVs in the U.S. market since January 1, 2005?

> No Yes\-- Please describe.
>
> [     \
> \
> ]{.underline}

IV-16. Does your firm sell its U.S.-produced FSVs over the internet in
the U.S. market?

> No Yes\-- Please describe, noting the estimated percentage of your
> firm's total 2007 U.S. commercial shipment value of its U.S.-produced
> FSVs accounted for by internet sales.
>
> [     \
> ]{.underline}

IV-17. Please identify the major raw materials used in your firm's
production of FSVs, the

approximate percentage change in the cost of each raw material since
January 1, 2005, and the share of your firm's total raw material costs
in 2007 accounted for by each raw material.

  ------------------------------- ------------------------ ------------------------
  [Raw material]{.underline}      [Change in cost since    [Share of total raw
                                  2005                     material cost in 2007
                                  (percent)]{.underline}   (percent)]{.underline}

  [     ]{.underline}             [     ]{.underline}      [     ]{.underline}

  [     ]{.underline}             [     ]{.underline}      [     ]{.underline}

  [     ]{.underline}             [     ]{.underline}      [     ]{.underline}

  [     ]{.underline}             [     ]{.underline}      [     ]{.underline}

  [     ]{.underline}             [     ]{.underline}      [     ]{.underline}
  ------------------------------- ------------------------ ------------------------

**Total 100%**

IV-18. Are the FSVs produced in the United States and in other countries
interchangeable (*i.e.*, can they physically be used in the same
applications) in the U.S. market? Please indicate below, using "A" to
indicate that the products from a specified country-pair are always
interchangeable, "F" to indicate that the products are frequently
interchangeable, "S" to indicate that the products are sometimes
interchangeable, "N" to indicate that the products are never
interchangeable, and "0" to indicate no familiarity with products from a
specified country-pair.^1^

+-------------+--------+-----------+----------+-----------+-----------+
| **Cou       | **C    | **Other   |          |           |           |
| ntry-pair** | hina** | countries |          |           |           |
|             |        | (spec     |          |           |           |
|             |        | ify)\--** |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
|             |        | **     ** | *        | **     ** |           |
|             |        |           | *     ** |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
| **United    |        |           |          |           |           |
| States**    |        |           |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
| **China**   |        |           |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
| ^1^ For any |        |           |          |           |           |
| c           |        |           |          |           |           |
| ountry-pair |        |           |          |           |           |
| producing   |        |           |          |           |           |
| FSVs which  |        |           |          |           |           |
| are         |        |           |          |           |           |
| *sometimes* |        |           |          |           |           |
| or *never*  |        |           |          |           |           |
| inter       |        |           |          |           |           |
| changeable, |        |           |          |           |           |
| please      |        |           |          |           |           |
| explain the |        |           |          |           |           |
| factors     |        |           |          |           |           |
| that limit  |        |           |          |           |           |
| or preclude |        |           |          |           |           |
| inte        |        |           |          |           |           |
| rchangeable |        |           |          |           |           |
| use:        |        |           |          |           |           |
|             |        |           |          |           |           |
| [     \     |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| ]{          |        |           |          |           |           |
| .underline} |        |           |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+

IV-19. Are differences other than price (*i.e.*, quality, availability,
transportation network, product range, technical support, *etc.*)
between FSVs produced in the United States and in other countries a
significant factor in your firm's domestic sales of its U.S.-produced
products? Please indicate below, using "A" to indicate that such
differences are always significant, "F" to indicate that such
differences are frequently significant, "S" to indicate that such
differences are sometimes significant, "N" to indicate that such
differences are never significant, and "0" to indicate no familiarity
with products from a specified country-pair.^1^

+-------------+--------+-----------+----------+-----------+-----------+
| **Cou       | **C    | **Other   |          |           |           |
| ntry-pair** | hina** | countries |          |           |           |
|             |        | (spec     |          |           |           |
|             |        | ify)\--** |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
|             |        | **     ** | *        | **     ** |           |
|             |        |           | *     ** |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
| **United    |        |           |          |           |           |
| States**    |        |           |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
| **China**   |        |           |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+
| ^1^ For any |        |           |          |           |           |
| c           |        |           |          |           |           |
| ountry-pair |        |           |          |           |           |
| for which   |        |           |          |           |           |
| factors     |        |           |          |           |           |
| other than  |        |           |          |           |           |
| price       |        |           |          |           |           |
| always or   |        |           |          |           |           |
| frequently  |        |           |          |           |           |
| are a       |        |           |          |           |           |
| significant |        |           |          |           |           |
| factor in   |        |           |          |           |           |
| your firm's |        |           |          |           |           |
| sales of    |        |           |          |           |           |
| FSVs,       |        |           |          |           |           |
| identify    |        |           |          |           |           |
| the         |        |           |          |           |           |
| c           |        |           |          |           |           |
| ountry-pair |        |           |          |           |           |
| and report  |        |           |          |           |           |
| the         |        |           |          |           |           |
| advantages  |        |           |          |           |           |
| or          |        |           |          |           |           |
| di          |        |           |          |           |           |
| sadvantages |        |           |          |           |           |
| imparted by |        |           |          |           |           |
| such        |        |           |          |           |           |
| factors:    |        |           |          |           |           |
|             |        |           |          |           |           |
| [     \     |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| \           |        |           |          |           |           |
| ]{          |        |           |          |           |           |
| .underline} |        |           |          |           |           |
+-------------+--------+-----------+----------+-----------+-----------+

IV-20. Please identify below the names and addresses of your firm's 10
largest customers for FSVs during 2005-2007. Please also provide the
name and telephone number of a contact person and the share of the
quantity of your firm's total 2007 U.S. commercial shipments value of
its U.S.-produced FSVs that each of these customers accounted for in
2007.

  --------- -------------- ----------------- -------------- ----------- ----------------
  **No.**   **Customer's   **Street address  **Contact      **Area code **Share of 2007
            name**         (not P.O. box),   person**       and         shipment-value
                           city, state, and                 telephone   (%)**
                           zip code**                       number**    

  **1**                                                                      

  **2**                                                                      

  **3**                                                                      

  **4**                                                                      

  **5**                                                                      

  **6**                                                                      

  **7**                                                                      

  **8**                                                                      

  **9**                                                                      

  **10**                                                                     
  --------- -------------- ----------------- -------------- ----------- ----------------

IV-21. **[COMPETITION FROM IMPORTS\--LOST REVENUES]{.underline}**.\--
**THIS SECTION IS TO BE COMPLETED ONLY BY NON-PETITIONERS.** (Note:
petitioners may provide allegations involving quotes made AFTER the
filing of the petition.)

> Since January 1, 2005: To avoid losing sales to competitors selling
> FSVs from China, did your firm:
>
> Reduce prices No Yes
>
> Roll back announced price increases No Yes
>
> If yes, please furnish as much of the following information as
> possible for each affected transaction. Document such allegations of
> lost revenues whenever possible (documentation could include copies of
> invoices, sales reports, or letters from customers). Please note that
> the Commission may contact the firms named to verify the allegations
> reported.
>
> Customer name, contact person, phone and fax numbers
>
> Specific product(s) involved
>
> Date of your initial price quotation
>
> Quantity involved
>
> Your initial ***rejected*** price quotation (total delivered value)
>
> Your ***accepted*** price quotation (total delivered value)
>
> The country of origin of the competing imported product
>
> The competing price quotation of the imported product (total delivered
> value)

  ------------- ------------- --------- ------------ ---------------------- ---------------------- ----------- ----------------------
  **Customer    **Product**   **Date of **Quantity   **Initial rejected     **Appected U.S. price  **Country   **Competing import
  name, contact               quote**   (units)**    U.S. price (total      (total                 of origin** price (total
  person, phone                                      value\--*dollars*)**   value\--*dollars*)**               value---*dollars*)**
  and fax                                                                                                      
  numbers**                                                                                                    

                                                                                                                    

                                                                                                                    

                                                                                                                    

                                                                                                                    
  ------------- ------------- --------- ------------ ---------------------- ---------------------- ----------- ----------------------

IV-22. **[COMPETITION FROM IMPORTS\--LOST SALES]{.underline}**.\--
**THIS SECTION IS TO BE COMPLETED ONLY BY NON-PETITIONERS.** (Note:
petitioners may provide allegations involving quotes made AFTER the
filing of the petition.)

> Since January 1, 2005: Did your firm lose sales of FSVs to imports of
> these products from China?

No Yes

> If yes, please furnish as much of the following information as
> possible for each affected transaction. Document such allegations of
> lost sales whenever possible (documentation could include copies of
> invoices, sales reports, or letters from customers). Please note that
> the Commission may contact the firms named to verify the allegations
> reported.
>
> Customer name, contact person, phone and fax numbers
>
> Specific product(s) involved
>
> Date of your price quotation
>
> Quantity involved
>
> Your rejected price quotation (total delivered value)
>
> The country of origin of the competing imported product
>
> The accepted price quotation of the imported product (total delivered
> value)

  -------------- ------------- --------- ------------ ---------------------- ----------- ----------------------
  **Customer     **Product**   **Date of **Quantity   **Rejected U.S. price  **Country   **Competing import
  name, contact                quote**   (units)**    (total                 of origin** price (total
  person, phone                                       value\--*dollars*)**               value---*dollars*)**
  and fax                                                                                
  numbers**                                                                              

                                                                                              

                                                                                              

                                                                                              

                                                                                              
  -------------- ------------- --------- ------------ ---------------------- ----------- ----------------------